Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine

International Immunology

Volumn 24, Issue 3, 2012, Pages 175-182

  Frasca, Daniela ^a   Diaz, Alain ^a   Romero, Maria ^a   Phillips, Mitch ^a   Mendez, Nicholas V ^a   Landin, Ana Marie ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; B lymphocytes; Biomarkers for vaccine response; Immunoglobulin class switch recombination; pH1N1

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; MESSENGER RNA; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BLAST CELL; CELLULAR IMMUNITY; DRUG RESPONSE; ENZYME INDUCTION; FEMALE; GROUPS BY AGE; HEMAGGLUTINATION INHIBITION; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MALE; MEMORY CELL; NORMAL HUMAN; PANDEMIC INFLUENZA; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMABLAST; PREDICTIVE VALUE; PRIORITY JOURNAL; VIRUS IMMUNITY;

EID: 84857609917     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr123     Document Type: Article

References (38)

1. Goodwin, K., Viboud, C. and Simonsen, L. 2006. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24:1159.
2. McElhaney, J. E. 2010. Influenza vaccine responses in older adults. Ageing Res. Rev. 10:379.
3. McElhaney, J. E. and Effros, R. B. 2009. Immunosenescence: what does it mean to health outcomes in older adults? Curr. Opin. Immunol. 21:418.
4. Simonsen, L., Taylor, R. J., Viboud, C., Miller, M. A. and Jackson, L. A. 2007. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis. 7:658.
5. Targonski, P. V., Jacobson, R. M. and Poland, G. A. 2007. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 25:3066.
6. Ferrucci, L., Guralnik, J. M., Pahor, M., Corti, M. C. and Havlik, R. J. 1997. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 277:728.
7. Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J. and Levandowski, R. A. 1995. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 123:518.
8. Monto, A. S., Ansaldi, F., Aspinall, R. et al. 2009. Influenza control in the 21st century: optimizing protection of older adults. Vaccine 27:5043.
9. Simonsen, L., Clarke, M. J., Schonberger, L. B., Arden, N. H., Cox, N. J. and Fukuda, K. 1998. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178:53.
10. Vu, T., Farish, S., Jenkins, M. and Kelly, H. 2002. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20:1831.
11. Jain, S., Kamimoto, L., Bramley, A. M. et al. 2009. Hospitalized patients with 2009 H1N1 influenza in the United States. N. Engl. J. Med. 361:1935.
12. Greenbaum, J. A., Kotturi, M. F., Kim, Y. et al. 2009. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc. Natl Acad. Sci USA 106:20365.
13. Hancock, K., Veguilla, V., Lu, X. et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945.
14. Marcelin, G., Bland, H. M., Negovetich, N. J. et al. 2010. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner. J. Infect. Dis. 202:1634.
15. Skowronski, D. M., Hottes, T. S., Janjua, N. Z. et al. 2010. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 182:1851.
16. Zhou, X. and McElhaney, J. E. 2011. Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans. Vaccine 29:2169.
17. Frasca, D., Landin, A. M., Lechner, S. C. et al. 2008. Aging downregulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J. Immunol. 180:5283.
18. Frasca, D., Diaz, A., Romero, M. et al. 2010. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 28:8077.
19. Bernasconi, N. L., Traggiai, E. and Lanzavecchia, A. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199.
20. Frasca, D., Diaz, A., Romero, M., Landin, A. M. and Blomberg, B. B. 2011. Age effects on B cells and humoral immunity in humans. Ageing Res. Rev. 10:330.
21. Wu, Y. C., Kipling, D., Leong, H. S., Martin, V., Ademokun, A. A. and Dunn-Walters, D. K. 2010. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 116:1070.
22. Wrammert, J., Koutsonanos, D., Li, G. M. et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181.
23. Wrammert, J., Smith, K., Miller, J. et al. 2008. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453:667.
24. Ito, T., Suzuki, Y., Mitnaul, L., Vines, A., Kida, H. and Kawaoka, Y. 1997. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 227:493.
25. Murasko, D.M., Bernstein, E. D., Gardner, E. M. et al. 2002. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp. Gerontol. 37:427.
26. Skowronski, D. M., Tweed, S. A. and De Serres, G. 2008. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J. Infect. Dis. 197:490.
27. Hsiung, G. D., Fong, C. K. Y. and Landry, M. L. eds., 1994. Diagnostic Virology. Yale University Press, New Haven, CT.
28. Clements, M. L., Betts, R. F., Tierney, E. L. and Murphy, B. R. 1986. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J. Clin. Microbiol. 24:157.
29. Crotty, S., Aubert, R. D., Glidewell, J. and Ahmed, R. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286:111.
30. Cox, R. J., Brokstad, K. A., Zuckerman, M. A., Wood, J. M., Haaheim, L. R. and Oxford, J. S. 1994. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 12:993.
31. Sasaki, S., Sullivan, M., Narvaez, C. F. et al. 2011. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 121:3109.
32. Sasaki, S., He, X. S., Holmes, T. H. et al. 2008. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 3:e2975.
33. de Bruijn, I. A., Remarque, E. J., Jol-van der Zijde, C. M., van Tol, M. J., Westendorp, R. G. and Knook, D. L. 1999. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J. Infect. Dis. 179:31.
34. Remarque, E. J., de Bruijn, I. A., Boersma, W. J., Masurel, N. and Ligthart, G. J. 1998. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J. Med. Virol. 55:82.
35. Remarque, E. J., de Jong, J. M., van der Klis, R. J., Masurel, N. and Ligthart, G. J. 1999. Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients. Exp. Gerontol. 34:109.
36. He, X. S., Sasaki, S., Narvaez, C. F. et al. 2011. Plasmablastderived polyclonal antibody response after influenza vaccination. J. Immunol. Methods 365:67.
37. Amanna, I. J., Carlson, N. E. and Slifka, M. K. 2007. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 357:1903.
38. Sallusto, F., Lanzavecchia, A., Araki, K. and Ahmed, R. 2010. From vaccines to memory and back. Immunity 33:451.